Department of Biophysics, All India Institute of Medical Sciences, New Delhi - 110029, India.
Protein Pept Lett. 2022;29(10):839-850. doi: 10.2174/0929866529666220816160517.
The ESKAPE group of pathogens which comprise of multidrug resistant bacteria, namely Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species are the cause of deadly nosocomial infections all over the world. While these pathogens have developed robust strategies to resist most antibiotics, their ability to form biofilms is one of their most combative properties. Hence there is an urgent need to discover new antibacterial agents which could prevent or destroy the biofilms made by these bacteria. Though it has been established that lactoferrin (LF), a potent iron binding antibacterial, antifungal, and antiviral protein displays anti-biofilm properties, its mechanisms of action, in addition to its iron chelation property, still remains unclear.
The binding and inhibition studies of LF with the enzyme Nucleoside diphosphate Kinase (NDK) and its elastase cleaved truncated 12 kDa fragment (12-NDK).
The characterization studies of NDK and 12-NDK using florescence spectroscopy, dynamic light scattering, size exclusion chromatography and ADP-glo Kinase Assay. Inhibition studies of LF-NDK using ADP-glo kinase assay, Surface Plasmon Resonance and Biofilm inhibition studies.
NDK and 12-NDK were cloned, expressed and purified from Acinetobacter baumannii and Pseudomonas aeruginosa. The characterization studies revealed NDK and 12-NDK from both species are stable and functional. The inhibition studies of LF-NDK revealed stable binding and inhibition of kinase activity by LF.
The binding and inhibition studies have shown that while LF binds with both the NDK and their truncated forms, it tends to have a higher binding affinity with the truncated 12 kDa fragments, resulting in their decreased kinase activity. This study essentially gives a new direction to the field of inhibition of biofilm formation, as it proves that LF has a novel mechanism of action in other than iron sequestration.
包含多药耐药菌的 ESKAPE 病原体,即屎肠球菌、金黄色葡萄球菌、肺炎克雷伯菌、鲍曼不动杆菌、铜绿假单胞菌和肠杆菌属,是全球致命医院获得性感染的原因。虽然这些病原体已经开发出强大的策略来抵抗大多数抗生素,但它们形成生物膜的能力是它们最具攻击性的特性之一。因此,迫切需要发现新的抗菌剂,可以防止或破坏这些细菌形成的生物膜。尽管已经确定乳铁蛋白 (LF) 是一种有效的铁结合抗菌、抗真菌和抗病毒蛋白,具有抗生物膜特性,但除了铁螯合特性之外,其作用机制仍不清楚。
LF 与酶核苷二磷酸激酶 (NDK) 及其弹性蛋白酶切割的 12 kDa 截断片段 (12-NDK) 的结合和抑制研究。
使用荧光光谱法、动态光散射、尺寸排阻色谱法和 ADP-glo 激酶测定法对 NDK 和 12-NDK 进行特征研究。使用 ADP-glo 激酶测定法、表面等离子体共振和生物膜抑制研究对 LF-NDK 的抑制研究。
NDK 和 12-NDK 已从鲍曼不动杆菌和铜绿假单胞菌中克隆、表达和纯化。特征研究表明,来自两种物种的 NDK 和 12-NDK 均稳定且功能正常。LF-NDK 的抑制研究表明 LF 与激酶活性稳定结合并抑制。
结合和抑制研究表明,虽然 LF 与 NDK 及其截断形式都结合,但它与截断的 12 kDa 片段具有更高的结合亲和力,导致其激酶活性降低。这项研究为生物膜形成抑制领域提供了一个新的方向,因为它证明 LF 在铁螯合以外具有新的作用机制。